Clinical trial
24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration.
NCT05299593 is registered in ClinicalTrials.gov with Fondazione G.B. Bietti, IRCCS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration.
- Lead sponsor
- Fondazione G.B. Bietti, IRCCS
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 4, 2020
- Completion date
- June 30, 2022
- Enrollment
- 43 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.